Skystar Bio-Pharmaceutical Company (Nasdaq: SKBI) updates on Hubei acquisition.

From the release: "The Company completed acquisition of a modern ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE